Due to the diversity of the samples, we were able to interrogate the data relative to several key breast cancer risk modifiers, such as age, parity and BRCA1 or BRCA2 germline mutations, enabling us to uncover cellular interactions and compositional changes associated with each factor. This evidence concerns the gene BRCA2 and breast cancer.